TY - JOUR
T1 - Allosteric small molecule modulators of nuclear receptors
AU - Meijer, Femke A.
AU - Leijten-van de Gevel, Iris A.
AU - de Vries, Rens M.J.M.
AU - Brunsveld, Luc
PY - 2019/4/5
Y1 - 2019/4/5
N2 - Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs.
AB - Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms. Allosteric modulation of NRs via synthetic small molecules has recently emerged as an interesting entry to address the need for small molecules targeting NRs in pathology, via novel modes of action and with beneficial profiles. In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs. Subsequently, the review focuses on examples of small molecules that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain. Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention. The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small molecular targeting of NRs.
KW - Allostery
KW - Drug discovery
KW - Ligands
KW - Nuclear receptors
UR - http://www.scopus.com/inward/record.url?scp=85061400831&partnerID=8YFLogxK
U2 - 10.1016/j.mce.2019.01.022
DO - 10.1016/j.mce.2019.01.022
M3 - Review article
C2 - 30703487
SN - 0303-7207
VL - 485
SP - 20
EP - 34
JO - Molecular and Cellular Endocrinology
JF - Molecular and Cellular Endocrinology
ER -